Evaluating birth outcomes following oral rilpivirine use in pregnancy in the United States : Findings from the antiretroviral pregnancy registry

Documenti analoghi

• Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy
  di: Tali Faggiano, et al.
  Pubblicazione: (2025)
• Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY cohort
  di: Jesús Troya, et al.
  Pubblicazione: (2026)
• Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)
  di: Kyle Ring, et al.
  Pubblicazione: (2024)
• Barriers for HIV testing during pregnancy in Southern Brazil
  di: Humberto Rosa
  Pubblicazione: (2006)
• Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’
  di: Sanjit Sah, et al.
  Pubblicazione: (2024)